Clinical Impact of Systemic Staging Studies in Secondary Breast Angiosarcoma.

ABSTRACT:

Background

Our goal was to evaluate the clinical impact of local and systemic imaging in secondary breast angiosarcoma (SBAS) at diagnosis (DX) and in follow-up (FU).

Materials and methods

Singe-center retrospective review of SBAS treated from 1/2007-7/2020. Clinicopathologic data was collected, including local and systemic imaging at DX and FU. The clinical impact of imaging was evaluated.

Results

Twenty patients had SBAS diagnosed 10.6±6.7 years following their index BC. All were diagnosed on exam. Mammogram, ultrasound, and breast MRI were commonly performed concurrently with DX (2.4 studies per patient) but did not impact clinical management. In-breast imaging extent of disease did not correlate with pathologic extent of disease (p=0.49). Systemic staging uncommon

SUBMITTER: Larson KE 

PROVIDER: S-EPMC11749825 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature